HER2 Support Group Forums - View Single Post - HER2-Positive Breast Cancer Patients Prefer Faster Subcutaneous Administration Of Her

News · 03-19-2013, 02:22 AM

Further research also reveals quicker administration of Herceptin could save NHS Â£15m compared to current practice1 Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St...

More...

03-19-2013, 02:22 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	HER2-Positive Breast Cancer Patients Prefer Faster Subcutaneous Administration Of Her Further research also reveals quicker administration of Herceptin could save NHS Â£15m compared to current practice1 Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St... More...